Report Details <\/p>\n
Translational Regenerative Medicine - new study showing you trends, R&D progress, and predicted revenues Where is the market for regenerative medicine heading? What are the commercial prospects for this market and related technologies? Visiongain's brand new report shows you potential revenues and other trends to 2025, discussing data, opportunities and prospects. <\/p>\n
Visiongain's report lets you assess regenerative medicine: cell-based therapies that aim to restore function and regenerate diseased tissues. Our 260 page report provides 145 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at world market, submarket and national level. You will see financial results, interviews, trends, opportunities and revenue predictions. <\/p>\n
Forecasts from 2015-2025 and other analyses show you commercial prospects Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and Porter's Five Forces), company profiles and commercial developments. Read the full transcript of an exclusive expert opinion interview from industry specialists informing your understanding and allowing you to assess prospects for investments and sales: Dr Antonio SJ Lee, CEO and Managing Director, MEDIPOST America Inc. <\/p>\n
You find prospects for key submarkets and products In addition to analyses of the overall world market, you see revenue forecasts for these three submarkets to 2025: Stem cell therapies Gene Therapies Tissue engineering products <\/p>\n
Products that can significantly increase disease-free survival and improve patient tolerance will achieve success. In the long term, we forecast these curative therapies to be adopted by many healthcare systems globally. <\/p>\n
Our investigation shows business research and analyses with individual revenue forecasts and discussions. You find dynamics of the industry and assess its potential sales, seeing agents likely to achieve the most success. <\/p>\n
To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com<\/a> <\/p>\n See revenue forecasts for products How will leading products perform to 2025 at the world level? Our study forecasts sales of currently marketed and pipeline regenerative medicine products including these: Osteocel Plus Trinity ELITE and Trinity Evolution Prochymal Apligraf Dermagraft ReCell Neovasculgen Glybera Talimogene Laherparepvec (T-Vec) <\/p>\n Discover how high revenues can go. You will see what is happening, understanding trends, challenges and opportunities. <\/p>\n <\/p>\n See the original post here:<\/p>\n Translational Regenerative Medicine: Market Prospects 2015-2025<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Report Details Translational Regenerative Medicine - new study showing you trends, R&D progress, and predicted revenues Where is the market for regenerative medicine heading? What are the commercial prospects for this market and related technologies? Continue reading